KRAS and melanoma: High EGFR promotes RAFi resistance in CRC, lung, melanoma and thyroid cancer cells by rapid feedback activation of EGFR signaling 113-117, and determines the G12Ci refractory state in KRAS G12C cancers 33, 34, 118-120.